Latham Advises Atai In $390M Merger With Beckley Psytech

By Corey Rothauser · June 3, 2025, 6:50 PM EDT

U.S.-German biopharmaceutical company atai Life Sciences, advised by Latham & Watkins LLP, said in an announcement Monday that it will acquire Beckley Psytech, led by Mayer Brown LLP and CMS Cameron...

To view the full article, register now.